Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation
Standard
Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation. / Jawad, Khalil; Feder, Stefan; Barten, Markus; Garbade, Jens.
in: EUR J CARDIO-THORAC, Jahrgang 54, Nr. 2, 01.08.2018, S. 400-401.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation
AU - Jawad, Khalil
AU - Feder, Stefan
AU - Barten, Markus
AU - Garbade, Jens
N1 - Editorial Material
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Heart transplantation is the gold standard therapy for patients diagnosed with end-stage heart failure. Despite the shortage of appropriate donor organs, the transplantation of hepatitis C-infected hearts is disputed. Previous research has shown that long-term results are controversial, and the risk of severe clinical infection should not be underestimated.
AB - Heart transplantation is the gold standard therapy for patients diagnosed with end-stage heart failure. Despite the shortage of appropriate donor organs, the transplantation of hepatitis C-infected hearts is disputed. Previous research has shown that long-term results are controversial, and the risk of severe clinical infection should not be underestimated.
KW - Adult
KW - Antiviral Agents/therapeutic use
KW - Echocardiography
KW - Heart Failure/surgery
KW - Heart Transplantation/adverse effects
KW - Hepatitis C/drug therapy
KW - Humans
KW - Male
KW - Tissue Donors
KW - Transplants/virology
KW - Viral Load
U2 - 10.1093/ejcts/ezy051
DO - 10.1093/ejcts/ezy051
M3 - Other (editorial matter etc.)
C2 - 29514173
VL - 54
SP - 400
EP - 401
JO - EUR J CARDIO-THORAC
JF - EUR J CARDIO-THORAC
SN - 1010-7940
IS - 2
ER -